CUMBERLAND PHARMACEUTICALS INC — Director's Dealing 2025

Sep 12, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CUMBERLAND PHARMACEUTICALS INC (CPIX)
CIK: 0001087294
Period of Report: 2025-08-01

Reporting Person: Jones James (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-01	Common Stock	P	13	$3.44	Acquired	43689	Direct
2025-08-04	Common Stock	P	13	$4.01	Acquired	43702	Direct
2025-08-05	Common Stock	P	13	$3.92	Acquired	43715	Direct
2025-08-06	Common Stock	P	13	$3.34	Acquired	43728	Direct
2025-08-07	Common Stock	P	13	$3.14	Acquired	43741	Direct
2025-08-08	Common Stock	P	13	$3.39	Acquired	43754	Direct
2025-08-11	Common Stock	P	13	$2.87	Acquired	43767	Direct
2025-08-12	Common Stock	P	13	$2.91	Acquired	43780	Direct
2025-08-13	Common Stock	P	13	$2.94	Acquired	43793	Direct
2025-08-14	Common Stock	P	13	$2.84	Acquired	43806	Direct
2025-08-15	Common Stock	P	13	$3.02	Acquired	43819	Direct
2025-08-18	Common Stock	P	13	$3.11	Acquired	43832	Direct
2025-08-19	Common Stock	P	13	$3.23	Acquired	43845	Direct
2025-08-20	Common Stock	P	2	$3.15	Acquired	43847	Direct
2025-08-21	Common Stock	P	13	$3.25	Acquired	43860	Direct
2025-08-22	Common Stock	P	13	$3.31	Acquired	43873	Direct
2025-08-25	Common Stock	P	13	$3.32	Acquired	43886	Direct
2025-08-26	Common Stock	P	13	$3.39	Acquired	43899	Direct
2025-08-27	Common Stock	P	13	$3.44	Acquired	43912	Direct
2025-08-28	Common Stock	P	13	$3.47	Acquired	43925	Direct
2025-08-29	Common Stock	P	13	$3.45	Acquired	43938	Direct

Footnotes

F1: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024.